29 results
8-K
EX-99.1
VBIVQ
VBI Vaccines Inc
15 May 23
VBI Vaccines Reports First Quarter 2023 Financial Results
8:00am
) spike proteins
Additional Corporate Updates
Leadership Appointments
April 2023: Nell Beattie appointed as Chief Financial Officer and Head of Corporate
8-K
EX-99.1
VBIVQ
VBI Vaccines Inc
25 Apr 23
VBI Vaccines Appoints Vaughn Himes to Board of Directors
8:00am
announcement of Pfizer’s intent to acquire the company. Prior to joining Seagen in 2009, Dr. Himes spent 20 years in leadership roles overseeing CMC
8-K
EX-99.1
6dbbyy5sxt jz
4 Apr 23
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
8:00am
8-K
EX-99.1
71him
12 Jul 22
VBI Vaccines Announces Appointment of John Dillman as Chief Commercial Officer
8:00am
8-K
EX-99.1
152zbk2rs z2xtds63d
7 Mar 22
VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2021, Provides Corporate Update and Outlook for 2022
8:00am
8-K
EX-99.1
vhow1d
7 Jul 21
VBI Vaccines Appoints Linda Bain to Board of Directors
9:25am
8-K
EX-99.1
mto90 6ok
7 Dec 20
VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine
10:23am
8-K
EX-99.1
0xq629zml9h
2 Dec 20
Regulation FD Disclosure
8:57am
8-K
c7yflq4 6r8uijnwmcc
2 Dec 20
Regulation FD Disclosure
8:57am
8-K
EX-99.1
1uajo pjd
17 Apr 19
VBI Vaccines Appoints Dr. Vlad Popovic as Vice President of Clinical Development and Medical Affairs
12:13pm